Quick Answer
GSK plc reported Total Assets of $61.12 billion for fiscal year 2025.
GSK plc — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $61.12B +2.8% |
$59.46B +0.8% |
$59.01B -1.9% |
$60.15B -24.0% |
$79.10B -1.7% |
$80.43B +0.9% |
| R&D Expense | $7.53B +17.6% |
$6.40B +2.9% |
$6.22B +13.4% |
$5.49B +9.3% |
$5.02B +4.7% |
$4.79B +4.9% |
| Gross Profit | $23.65B +5.9% |
$22.33B +2.6% |
$21.76B +10.1% |
$19.77B +19.6% |
$16.53B +0.7% |
$16.43B -25.0% |
- GSK plc reported Total Assets of $61.12 billion for fiscal year 2025.
- GSK plc showed an increase of +2.8% in Total Assets compared to the prior fiscal year.
- GSK plc reported R&D Expense of $7.53 billion for fiscal year 2025.
- GSK plc showed an increase of +17.6% in R&D Expense compared to the prior fiscal year.
- GSK plc reported Gross Profit of $23.65 billion for fiscal year 2025.
- GSK plc showed an increase of +5.9% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: